These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 25727910)

  • 1. Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells.
    Lim J; Choi HS; Choi HJ
    J Neurochem; 2015 May; 133(4):544-57. PubMed ID: 25727910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERRγ ligand HPB2 upregulates BDNF-TrkB and enhances dopaminergic neuronal phenotype.
    Kim HI; Lee S; Lim J; Chung S; Koo TS; Ji YG; Suh YG; Son WS; Kim SH; Choi HJ
    Pharmacol Res; 2021 Mar; 165():105423. PubMed ID: 33434621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of dopaminergic neuronal phenotypes by the estrogen-related receptor gamma ligand GSK4716 via the activation of CREB signaling.
    Lim J; Kim HI; Choi HJ
    Neurochem Int; 2020 Jun; 136():104726. PubMed ID: 32173553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1α upregulates tyrosine hydroxylase and dopamine transporter by nuclear receptor ERRγ in SH-SY5Y cells.
    Lim J; Kim HI; Bang Y; Seol W; Choi HS; Choi HJ
    Neuroreport; 2015 Apr; 26(6):380-6. PubMed ID: 25807177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway.
    Kim S; Lim J; Bang Y; Moon J; Kwon MS; Hong JT; Jeon J; Seo H; Choi HJ
    Mol Neurobiol; 2018 Feb; 55(2):1607-1619. PubMed ID: 28190238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new ERRγ agonists regulating dopaminergic neuronal phenotype in SH-SY5Y cells.
    Kim T; Kim HI; Oh H; Jeon Y; Shin H; Kim HS; Lim J; Lim C; Yoo J; Suh YG; Son WS; Choi HJ; Kim SH
    Bioorg Chem; 2022 May; 122():105716. PubMed ID: 35303621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.
    Ramalingam M; Kim SJ
    J Cell Biochem; 2016 Apr; 117(4):917-26. PubMed ID: 26364587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
    Xie HR; Hu LS; Li GY
    Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human platelet lysate supports SH-SY5Y neuroblastoma cell proliferation and differentiation into a dopaminergic-like neuronal phenotype under xenogeneic-free culture conditions.
    Ribeiro M; Campos J; Pinho TS; Sampaio-Marques B; Barata-Antunes S; Cibrão JR; Araújo R; Duarte-Silva S; Moreira E; Sousa RA; Costa PM; Salgado AJ
    Biotechnol J; 2024 Jul; 19(7):e2400068. PubMed ID: 38987218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells.
    Ducray AD; Wiedmer L; Herren F; Widmer HR; Mevissen M
    CNS Neurol Disord Drug Targets; 2020; 19(8):618-629. PubMed ID: 32640966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells.
    Pan J; Kao YL; Joshi S; Jeetendran S; Dipette D; Singh US
    J Neurochem; 2005 May; 93(3):571-83. PubMed ID: 15836616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
    Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
    Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear RXRα and RXRβ receptors exert distinct and opposite effects on RA-mediated neuroblastoma differentiation.
    Girardi CS; Rostirolla DC; Lini FJM; Brum PO; Delgado J; Ribeiro CT; Teixeira AA; Peixoto DO; Heimfarth L; Kunzler A; Moreira JCF; Gelain DP
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):317-328. PubMed ID: 30529222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling.
    Korecka JA; van Kesteren RE; Blaas E; Spitzer SO; Kamstra JH; Smit AB; Swaab DF; Verhaagen J; Bossers K
    PLoS One; 2013; 8(5):e63862. PubMed ID: 23724009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
    Jalava A; Akerman K; Heikkilä J
    J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JNK pathway is required for retinoic acid-induced neurite outgrowth of human neuroblastoma, SH-SY5Y.
    Yu YM; Han PL; Lee JK
    Neuroreport; 2003 May; 14(7):941-5. PubMed ID: 12802179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.
    Coccini T; Vecchio S; Crevani M; De Simone U
    Neurotox Res; 2019 Jan; 35(1):49-62. PubMed ID: 29934755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
    Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
    Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin-Mediated Changes in Microtubule-Associated Proteins and Retinoic Acid-Induced Neurite Outgrowth in SH-SY5Y Cells.
    Paik S; Somvanshi RK; Kumar U
    J Mol Neurosci; 2019 May; 68(1):120-134. PubMed ID: 30879180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.